National Post (National Edition)

Pot-stock earnings to sort winners from losers

Four cannabis companies report this week

- KRISTINE OWRAM

Four of Canada’s largest pot companies report earnings this coming week, and while it’s too early for any postlegali­zation numbers, executive commentary should begin to divide the winners from the losers.

Aurora Cannabis Inc. will report pre-market Monday, followed by Cronos Group Inc. on Tuesday morning, Tilray Inc. post-market Tuesday and Canopy Growth Corp. on Wednesday morning. It will be the first chance for many analysts and investors to hear from executives since Canada legalized recreation­al cannabis use on Oct. 17, a move that was followed by supply shortages across the country.

Any commentary on postlegali­zation sales and the supply bottleneck will be closely parsed by the investment community, but the selling, general and administra­tive expense line, or SG&A, could be more revealing, said Martin Landry, an analyst at GMP Securities.

“That’s what’s going to tell us the break-even level needed to reach profitabil­ity,” Landry said. “Some licensed producers have very heavy SG&A structures at this point that will impair their profitabil­ity levels and others are very lean.”

Average selling price, cost of production and run-rate production levels will be other key metrics to watch, said Bruce Campbell, founder of StoneCastl­e Investment Management Inc. and chief investment officer at Cannabis Growth Opportunit­y Corp., a publicly traded investment company.

“Then we can start to figure out, when they pull off their next harvest, how much money is that going to mean in the till if it goes to the provinces and is immediatel­y sold?” he said.

Campbell has been reposition­ing his portfolio ahead of earnings, buying U.S.-focused stocks like Curaleaf Holdings Inc., 1933 Industries Inc., Cannex Capital Holdings Inc. and C21 Investment­s Inc. while trimming his exposure to Canadian licensed producers.

Pot stocks got a boost earlier this week from U.S. midterm election wins and the resignatio­n of anti-marijuana Attorney General Jeff Sessions, although the optimism faded the following day, pressuring shares.

The stocks have largely moved in tandem to date but that’s expected to change as the impact of legalizati­on becomes clearer. While investors are likely to watch earnings more closely this quarter than they have in the past, it will probably take a couple more reports before obvious winners and losers emerge.

“I think the real picture for us will be the March quarter,” Landry said. “Some of the kinks will have been worked out and we’re going to get a better sense of results when there’s less growing pains and smoother operations.”

Investors should keep in mind that the Canadian results are “a small portion of the overall story” as internatio­nal markets open up, according to Stifel analyst Christophe­r Growe.

“Investment decisions based entirely on the initial results of the recreation­al market would likely be extremely short-sighted,” Growe wrote in a note.

 ?? MICHAEL NAGLE / BLOOMBERG ?? Aurora Cannabis Inc. reports earnings Monday, followed by Cronos Group Inc. and Tilray Inc. on Tuesday and Canopy Growth Corp. on Wednesday.
MICHAEL NAGLE / BLOOMBERG Aurora Cannabis Inc. reports earnings Monday, followed by Cronos Group Inc. and Tilray Inc. on Tuesday and Canopy Growth Corp. on Wednesday.

Newspapers in English

Newspapers from Canada